台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    62.7
  • 漲跌
    ▼0.9
  • 漲幅
    -1.42%
  • 成交量
    94
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-群益金鼎-中港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-中港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/13862.6100.0062.7081415.67%
2024/12/11262.8000.0063.9021391.43%
2024/12/10262.8500.0062.8021391.43%
2024/12/09663.2700.0062.8061424.22%
2024/12/0600.00763.8063.90-7141-4.96%
2024/12/05164.8000.0064.2011420.70%
2024/12/0400.00165.5065.10-1143-0.70%
2024/12/03263.3000.0063.8021411.41%
2024/11/28863.6400.0063.3081455.50%
2024/11/25263.6000.0064.3021481.34%
2024/11/20564.3600.0063.8051483.36%
2024/09/1800.00356.9756.30-3157-1.91%
2024/09/10655.9200.0055.6061623.68%
2024/09/09156.8000.0056.8011620.62%
2024/08/29359.4000.0059.2031741.72%
2024/08/1600.00258.4057.80-2187-1.07%
2024/08/1500.00257.7058.20-2191-1.05%
2024/08/09456.2000.0056.2042031.97%
2024/05/0700.002362.5462.30-23284-8.10%
2024/05/0600.00861.0360.40-8273-2.93%
2024/05/03259.4000.0059.5022690.74%
2024/05/0200.00360.4060.50-3268-1.12%
2024/04/30458.9300.0058.6042651.51%
2024/04/2900.00560.5660.30-5264-1.89%
2024/04/2600.00460.8560.30-4263-1.52%
2024/04/25658.38158.2059.0052581.93%
2024/04/24459.2300.0059.5042571.56%
2024/04/23161.101360.8860.70-12255-4.70%
2024/04/2200.00157.0056.70-1248-0.40%
2024/04/1800.00156.6056.10-1249-0.40%
2024/04/1600.00154.9055.00-1257-0.39%
2024/04/15256.2000.0055.9022590.77%
2024/04/10357.9300.0058.0032581.16%
2024/04/09558.0600.0057.7052581.94%
2024/03/2800.00358.9358.50-3254-1.18%
2024/03/2700.00758.7758.30-7254-2.76%
2024/03/26356.4000.0056.4032521.19%
2024/03/18254.2500.0054.2022500.80%
2024/03/07556.0200.0056.6052452.03%
2024/03/06859.3800.0058.0082383.36%
2024/03/05560.862060.8961.20-15228-6.57%
2024/03/04961.7600.0061.1092263.97%
2024/02/29262.6500.0063.6022200.91%
2024/02/20956.4800.0056.3091635.51%
2023/11/1500.000.150.7050.10-0.1339-0.04%
2023/11/070.157.0000.0057.900.12560.05%
2023/11/0600.00152.0054.80-1209-0.48%
2023/11/03151.9000.0052.0011730.58%
2023/08/0100.00148.5048.40-177-1.29%
2023/07/3100.00448.5048.40-475-5.27%
2023/07/14145.4000.0045.601452.21%
2022/12/26549.47548.6848.600900.00%
2022/10/1300.00240.4040.40-2315-0.63%
2022/10/07244.7500.0044.3023110.64%
2022/09/07149.45148.8048.8002720.00%
2022/09/061548.16248.9348.65132674.87%
2022/09/05949.93849.0049.0012540.39%
2022/09/01147.7500.0047.1012220.45%
2022/08/2300.00146.9546.95-1197-0.51%
2022/08/22147.15145.5047.4001900.00%
2022/08/19145.5500.0045.5511810.55%
2022/07/28345.97344.9044.2001130.00%
2022/07/26346.78447.0645.90-198-1.01%
2022/07/25347.13247.5547.951801.24%
2022/04/2500.00344.7043.80-349-6.05%
2022/04/21345.1000.0044.903476.27%
2022/04/191045.00144.8044.9094619.33%
2022/04/18345.22245.3045.251452.19%
2022/04/0600.00143.3043.25-140-2.46%
2022/03/29143.0000.0043.101422.35%
2022/03/1500.00142.2042.45-143-2.30%
2022/03/14142.6500.0042.751432.28%
2022/01/0300.00144.2043.80-197-1.02%
2021/12/30144.5000.0044.501971.03%
2021/10/2600.00147.5546.35-183-1.19%
2021/10/21147.5000.0045.301691.43%
2021/06/0400.00144.0044.00-1198-0.50%
2021/05/24142.4000.0042.0011780.56%
2021/04/28149.0500.0047.8011070.93%
2020/07/1700.00167.9065.90-1113-0.88%
2020/07/09167.4000.0071.901991.01%
2019/08/0800.00175.4075.50-140-2.50%
2019/07/08169.20168.4068.400260.00%
2019/05/3100.00167.9068.30-142-2.37%
2019/05/24166.6000.0067.401432.28%
2018/03/3000.00472.1572.40-4163-2.45%
2018/03/2800.00171.3070.00-1158-0.63%
2018/03/26571.3000.0071.3051573.17%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章